WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

A ALIMENTARY TRACT AND METABOLISM
A02 DRUGS FOR ACID RELATED DISORDERS

A02A ANTACIDS

This group comprises plain antacid drugs, antacids in combination with antiflatulents and antacids in combination with other drugs.
Antacids in combination with liquorice root or linseed are classified in this group.
Plain antiflatulents, see A03AX - Other drugs for functional gastrointestinal disorders.

The DDDs for antacids are based on treatment of hyperacidity and dyspepsia, not ulcus. One exception, however, is antacids in combination with antispasmodics in A02AG, where the DDDs are based on treatment of ulcus.
For ordinary salt combinations in A02AD, fixed doses are used instead of individual doses for every single preparation (10 tablets = 10 UD; 50 ml mixture = 10 UD).

A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

Peptic ulcer includes ulcers in the oesophagus, stomach or duodenum.
Combinations with H2-receptor antagonists are classified in A02B.
See also A03 - Drugs for functional gastrointestinal disorders.
Antacids in combination with liquorice root or linseed are classified in A02A - Antacids.
Combinations with NSAIDs are classified in M01A.

A02X OTHER DRUGS FOR ACID RELATED DISORDERS

This group comprises preparations, which cannot be classified in the preceding groups.

Last updated: 2024-01-26